INTRODUCTION
Oral route is the most convenient and extensively used route for drug administration. Over the years the oral dosage forms have become sophisticated with development of controlled release drug delivery system (CRDDS).
1
Oral delivery of drugs is one of the easiest route of drug delivery due to the ease of administration, patient compliance and flexibility in formulation etc. From immediate release to site specific delivery, oral dosage forms have really progressed. Gastroretentive dosage forms significantly extend the period of time, over which drug may be released and thus prolong dosing intervals and increase patient compliance. Such retention systems are important for those drug that are degraded in the intestine like antacids or certain antibiotics, enzymes that act locally in the stomach. This systems can be retained in the stomach and assist in improving the oral sustained delivery of drugs that have an absorption window in a particular region of the gastrointestinal tract, thus ensuring optimal bioavailability.
2- 3 The retentive characteristics of the dosage form are not significant for the drugs that: They Are insoluble in intestinal fluids Act locally to overcome these limitations, various approaches have been proposed to increase gastric residence of drug delivery systems in the upper part of the gastrointestinal tract includes floating drug dosage systems (FDDS) swelling or expanding systems , mucoadhesive systems , modified-shape systems , high-density system , and other delayed gastric emptying devices. Among these systems, FDDS have been most commonly used. 4 During the early 1980s, Marshall and Warren first time isolated a spiral, urease producing, flagellate gramnegative bacterium that was later identified as Helicobacter pylori, a causative factor in the etiology of peptic ulcer disease. H. pylori appear to be responsible for 95% of the cases of gastritis and 65% of gastric ulcers. Although most individuals with H. pylori are asymptomatic, there is now convincing evidence that this bacterium is the major etiologic factor in chronic dyspepsia, H. pylori-positive duodenal and gastric ulcers and gastric malignancy. Consequently, H. pylori eradication is now recognized to be the correct approach along with conventional therapies in the treatment of the disease. Options that have been considered to treat peptic ulcer disease include taking drugs such as antacids, H-blockers (antihistaminics), antimuscarinics, proton pump inhibitors and
ABSTACT
The aim of the current study was to design oral controlled release gastro-retentive drug delivery of Tinidazole. that are designed to retain in the stomach for a long time and have developed as a Local drug delivery system for better eradication of Helicobacter Pylori in peptic ulcer diseases. Tablets were prepared by direct compression and evaluated for evaluated for various physical parameters, Hardness, friability, drug Content, floating ability, Lag time, Swelling Index studies, and in vitro dissolution parameters as well as kinetics of release were assessed. Factorial design for 2 factors at 3 levels each was employed to systematically optimize drug release profile and Floating Behavior. Sodium Alginate and Hydroxy Propyl Metheyl Celluiose (HPMC K15M) were taken as the independent variables. Response surface plots and contour plots were drawn. Compressed tablets exhibited zero order drug release kinetics, resulting in regulated and complete release until 12 hours. Polynomial mathematical models, generated for various response variables using multiple linear regression analysis, were found to be statistically significant (P < 0.05).Both the polymers had significant effect on the release profiles of the tablets, Besides unraveling the effect of the 2 factors on the various response variables, the study helped in finding the optimum Formulation "F4" with Floating Lag Time (20 sec.) and having controlled release upto 12 hours (99.47%). Meanwhile, sustained profiles of drug release were also obtained. In general, these systems can float in the gastric conditions and control the drug release from the tablets. combination therapy for gastritis associated with H. pylori. The bacterium is also considered a risk factor for the development of gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. The eradication of H. pylori is limited by its unique characteristics. Once acquired, it penetrates the gastric mucus layer and fixes itself to various phospholipids and glycolipids on the epithelial surface. Therefore, the organism exclusively resides on the luminal surface of the gastric mucosa under the mucus gel layer in the acidic environment of the stomach as per Fig. 1 The bacteria is S-shaped, gram-negative, having flagella as shown in fig.12 
5-6
Tinidazole,1-[2-(ethylsulfonyl)ethyl]2-methyl-5-nitroimidazole-1-ethanol, is a nitroimidazole derivative with activity against anaerobic protozoa, aerobic and microaerophilic bacteria. Common adverse effects of Tinidazole involve the gastrointestinal tract and the neurological system with high doses. Therefore, reduction of side effects of Tinidazole (plasma peak levels) while prolonging its action by using controlled oral dosage forms is highly desirable. Using various polymers can control drug release. The present study aimed to develop controlled release Floating Drug Delivery System (FDDS), which will remain in stomach for 12 hours while controlling drug release to achieve target release profile using a combination of Hydroxy Propyl Methyl Cellulose (HPMC K 15 M) and Sodium Alginate as Polymer.
MATERIALS AND METHODS
Tinidazole was received as a gift sample from Aarti Drug Lab (Mumbai, India) Hydroxy propyl methylcellulose K-15M (HPMC-K15M) was obtained from Colorcon Asia Pvt Ltd (Goa, India) and Microcrystalline cellulose was received as a gift sample from Colorcon Asia Pvt Ltd (Goa, India) . Sodium bicarbonate, citric acid, magnesium stearate, talc were purchased from Poona Chemicals Laboratories (Pune, India). All other chemicals were of analytical grades as required.
Methods
Effervescent Floating tablets containing Tinidazole were prepared by direct compression technique using varying concentrations of different grades of polymers with Sodium bicarbonate and citric acid. All the ingredients were accurately weighed and passed through different mesh sieves accordingly. Then, except Magnesium stearate all other ingredients were blended uniformly in glass mortar After sufficient mixing of drug as well as other components, Magnesium stearate was added, as post lubricant, and further mixed for additional 2-3 minutes. The tablets were compressed using rotary tablet machine. The weights of the tablets were kept constant for all formulation
Experimental

Characterization of Tinidazole 7
Description: The sample of tinidazole was analyzed for its nature, color and taste.
Melting Point: The melting point was taken by open capillary method.
Standard Curve of Tinidazole:
Tinidazole has been quantitatively analyzed by various techniques. In present studies ,Tinidazole was estimated by UV Spectrophotometry method.
Infrared spectra analysis: 8 Infrared spectrum of Tinidazole was determined on Fourier Transform Infrared Spectrophotometer (FTIR-4100s) using KBr dispersion method. The base line correction was done using dried potassium bromide. Then the spectrum of dried mixture of drug and potassium bromide was run.
Differential scanning calorimetry: DSC was performed in order to assess the thermotropic properties and thermal behavior of Tinidazole. About 5 mg of the sample were sealed in the aluminum pans and heated at the rate of 10 0 C/min, covering a temperature range of 40 0 C to 300 0 C under nitrogen atmosphere of flow rate 100 ml/min.
Ultraviolet (UV) spectroscopy:
7 UV spectrum of 25 μg/ml solution of the drug powder in 0.1 N aqueous hydrochloric acid solution was recorded in the range of wavelengths from 200nm to 400nm using UV-visible Double beam Spectrophotometer (UV-Chemito-2600). Before selection of ratio of two polymers that is HPMC K15M and Sodium Alginate, low and high levels of independent variables should be fixed. This was achieved by preparation of some preliminary formulations. Initially Sodium Alginate shows better swelling index than HPMC K15M at low concentration but at 12 hours HPMC K15M shows high swelling, However matrix erosion of HPMC K15M was higher than Sodium alginate at low Conc.as a result release of drug from HPMC K15M matrix will be higher at than required.
Hence lower levels of Sodium alginate and higher levels of HPMC K15M were selected for factorial design. Based on the results obtained with preliminary formulations, 3 2 randomized full factorial designs were applied in the present study. In this design 2 factors will be evaluated, each at 3 levels, and experimental trials will be performed at all 9 possible combinations. The amount of polymer that is HPMC K15M and Sodium alginate was selected as independent variables. The Floating Lag Time, cumulative percent drug released in 1 & 10 hrs (Q1 & Q10) is selected as dependent variables. The probable formulations using 3 2 randomized full factorial designs are as shown in the Table 3 . So the possible combinations of two independent factors having three levels can be given as,
Preparation of Floating Tablet of Tinidazole:
8-9
Floating tablets each containing 300mg of Tinidazole were prepared in different proportions of drug and polymer as per given in (Table 3) . Different tablet formulations were prepared by direct compression method 8, 9 . All the powders passed through Sieve No.
60. The required quantities of medicament and polymers were mixed thoroughly in a glass mortar by following geometric dilution technique. Then it was mixed with sodium bicarbonate and lubricated with magnesium stearate (1%w/w) . Then the tablets were compressed in compression machine at specified pressure with 12mm oval punch. The flow properties of powder blend (before compression) were characterized in terms of angle of repose, tapped density, bulk density, Carr"s index and Hausner"s ratio.
Post compression parametersi) Thickness and diameter 12 . The thickness and diameter of the tablet was measured using vernier callipers. It is expressed in mm. Five tablets were used and average values were calculated.
ii) Hardness
It indicates the ability of a tablet to withstand mechanical shocks while handling. The hardness of the tablets was determined using Pfizer hardness tester. The value was noted in kg/cm2.Three tablets were randomly picked and the hardness of the tablets was determined.
iii) Weight variation
Randomly selected twenty tablets were weighed individually and together in a single pan balance. The average weight was noted and standard deviation was calculated [13, 14] . The tablet passes the test if not more than two tablets fall outside the percentage limit and none of the tablet differs by more than double percentage limit.
% Deviation = (Wavg -Winitial) / Wavg × 100
where, Wavg -average weight of tablet, Winitalindividual weight of tablet.
iv) Friability
Tablet strength was tested by Roche Friabilator. It is expressed in percentage (%). Ten tablets were initially weighed (W0) and into Friabilator [15] . The Friabilator was operated at 25rpm for 4min or run up to 100 revolutions. The tablets were weighed again (W). The % friability was then calculated by:
% Friability = (W0-W/ W0) ×100
where, W0 -initial weight of tablets, W -final weight of tablets. % Friability of tablets less than 1% are considered acceptable.
v) In vitro buoyancy studies
The in vitro buoyancy was determined by floating lag time method. The tablets were placed in 250 mL beaker containing 0.1N HCl [16] . The time required for the tablets to rise to the surface and float was determined as floating lag time (FLT). The time between introduction of dosage form and its buoyancy in 0.1N HCl and the time during which the dosage form remain buoyant were measured. The total duration of time by which the dosage form remains buoyant is called total floating time (TFT).
Swelling study
Swelling of hydrophilic polymer such as Hydroxy Propyl Methyl Cellulose greatly depends upon the contents of the stomach and the osmolarity of the medium. These eventually influences the release, slowing action and the residence time. For each formulation, one tablet was weighed and placed in a beaker containing 200 ml of distilled water. After each hour the tablet was removed from beaker and weighed again upto 8 hours. The percentage weight gain by the tablet was calculated by using the formula.
Swelling index (S.I) = {(Wt-Wo)/Wo} x 100
Where, S.I. = swelling index Wt = Weight of tablet at time t Wo = Weight of tablet before immersion.
In vitro drug release
In vitro drug release of the samples was carried out using type-II dissolution apparatus (Paddle type). The dissolution medium, 900mL of 0.1N HCl buffer was placed into the dissolution flask maintaining the temperature of 37±0.5ºC and 50rpm
17. Tablet was placed in each vessel and operated the apparatus at 50 rpm for 12h. Withdrawn 5mL of the sample solution from each vessel through 5mL syringes after 1, 2, 4, 6, 8, 10, 12h and replaced with equal volume of fresh dissolution medium previously equilibrated to 37 ± 0.5°C. Each sample was filtered through 0.45μm filter and collected in separate vials. 
Data analysis:
19-22
To analyze the mechanism of release and release rate kinetics of the dosage form, the data obtained were fitted into Zero order, First order, Higuchi matrix, Peppas and Hixson Crowell model using PCP-DISSOv3 software.
RESULTS AND DISCUSSION
Pre compression parameters
All the pre-compressional parameters like bulk density, tapped density, angle of repose, Carr"s index, Hausner"s ratio etc were evaluated and were found to be within the limits, indicating the power blend has the required flow property for compression. The tablets were prepared by direct compression method. In the Preformulation studies, compatibility studies were performed using FTIR spectrophotometer. The FTIR spectrum of pure drug and physical mixture of drug and polymer were studied. The peaks obtained in the spectra"s of each formulation correlated with the peaks of pure drug spectrum. So it was concluded that no significant difference in peak pattern in IR spectrum of drug, polymer and the excipients exists. The values obtained for the preformulation parameters for the formulations F1 to F9 are tabulated in Table 4 . * All values are mean ± SD, (n = 3).
Post compression parameters
Hardness of the tablet was in the range 5.21±0.1 to 5.37± 0.24 kg/cm2. Weight loss in the friability test was in the range 0.24±0.01 to 0.62±0.02% (Table 5 ). All the floating tablets prepared contained Tinidazole within the range of 100±4 % of the labeled claim. 
In vitro buoyancy studies
Buoyancy studies were performed using 0.1N HCl solution pH1.2 buffer at 37°C (Table 4) ; the tablets floated and remained without disintegration. 
B-Brust
Swelling study
Swelling study was performed for all the formulations F1-F9 for 12h (Table 7) . Swelling increases as the time passes because the polymer gradually absorbs water due to hydrophilicity of polymer. 
In vitro drug release
Preliminary formulation: From the in-vitro results it was observed that as the concentration of Sod. Alginate increases, the release rate of Tinidazole from the formulations reduces which indicates release retardant nature of Sod. Alginate as shown in Table 8 . 
Release kinetics
The release data were analyzed as per Zero order, First order, Higuchi"s and Peppas equation models to know the pattern of drug release and mechanism of drug release from the Floating tablets. Three-dimensional response surface plots are presented in Figure 7 shows that cumulative drug release increases with decrease in concentrations of polymer. The Contour plots showing the effect of polymer concentration on the Y 1 (cumulative drug release at 1 hr) is shown in Figure 7 Three-dimensional response surface plots are presented in Figure 9 shows that Floating lag time increases with increases in concentrations of HPMC K15M and Sodium alginate. Therefore it can be derived that the change in concentration of polymer had significant effect on the Floating lag time of the formulation.
CONCLUSION:
Regulated drug release in zero-order manner attained in the current study indicates that the optimized gastro-retentive tablet of Tinidazole, prepared using Sodium Alginate and HPMC K15M can successfully be employed as a oral controlled release drug delivery system. High Floating ability of the formulation is likely to increase its GI residence time, and eventually, improve the extent of bioavailability. However, appropriate balancing between various levels of the two polymers is imperative to acquire proper controlled release and byouncy. 3 2 factorial design is quite efficient in optimizing gastro-retentive drug delivery system of Tinidazole. Floating tablet of Tinidazole can be successfully employed for eradication of H.pylori infection which is main cause of gastric ulcers. Gastroretentive dosage form of Tinidazole will reduce the frequency of administration of drug and helps to minimize dose of drug and side effects associated with the drug. 
